James Huang - 22 Feb 2023 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
Director
Signature
/s/ James Huang
Issuer symbol
WINT
Transactions as of
22 Feb 2023
Net transactions value
+$156,947
Form type
4
Filing time
23 Feb 2023, 15:30:23 UTC
Previous filing
08 Sep 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Exercise of in-the-money or at-the-money derivative security $156,947 +1,112,308 +48% $0.1411 3,449,161 22 Feb 2023 See Footnote F1
holding WINT Common Stock 296,281 22 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WINT Warrants (right to purchase) Disposed to Issuer $0 -275,862 -100% $0.000000* 0 22 Feb 2023 Common Stock 275,862 $7.98 See Footnote F1, F2
transaction WINT Warrants (right to purchase) Disposed to Issuer $0 -275,938 -100% $0.000000* 0 22 Feb 2023 Common Stock 275,938 $12.09 See Footnote F1, F2
transaction WINT Warrants (right to purchase) Disposed to Issuer $0 -498,008 -100% $0.000000* 0 22 Feb 2023 Common Stock 498,008 $12.15 See Footnote F1, F2
transaction WINT Warrants (right to purchase) Disposed to Issuer $0 -62,500 -100% $0.000000* 0 22 Feb 2023 Common Stock 62,500 $12.00 See Footnote F1, F2
transaction WINT Warrants (right to purchase) Award $0 +1,112,308 $0.000000 1,112,308 22 Feb 2023 Common Stock 1,112,308 $0.1411 See Footnote F1, F2
transaction WINT Warrants (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -1,112,308 -100% $0.000000* 0 22 Feb 2023 Common Stock 1,112,308 $0.1411 See Footnote F1
transaction WINT Warrants (right to purchase) Award $0 +2,224,616 $0.000000 2,224,616 22 Feb 2023 Common Stock 2,224,616 $0.2152 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held by Panacea Venture Healthcare Fund I L.P. ("Panacea Healthcare"), over which the reporting person may be deemed to indirectly share beneficial ownership. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
F2 Pursuant to a warrant exercise inducement offer letter, the Issuer and Panacea Healthcare agreed to amend the outstanding warrants held by Panacea Healthcare to lower the exercise price to $0.1411 and to issue Panacea Healthcare warrants to purchase an additional 2,224,616 shares of Common Stock, in exchange for Panacea Healthcare agreeing to immediately exercise the repriced warrants.